MetaCell s.r.o., a biotechnology company on the field of cell separation and cultivation procedures expansion, is developing a new, diagnostic assay for personalized medicine. The test could be used in early detection, diagnosis and monitoring of cancer and endometriosis treatment.

MetaCell s.r.o. provides customized contract services for in vivo and in vitro drug evaluation including developing experimental cancer models, design of individual protocols, performing entire research projects as well as expertise data analysis and reports. Ongoing data feedback maximizes the flow of information, allowing optimum study flexibility and the development of the possibly best solutions, with the overall process being facilitated by a dedicated Project Coordinator.

MetaCell s.r.o. has developed some novel technologies including the methodology of the human and animal cancers circulating tumor cells and circulating endometriosis cells capture.